NO20034381D0 - Kombinasjonsdose av cyklooksygenaseinhibitor, en vitamin-D3- omfattende analog og metabolitter derav, og/eller kalsium for forebyggelse avepitelial kreft - Google Patents

Kombinasjonsdose av cyklooksygenaseinhibitor, en vitamin-D3- omfattende analog og metabolitter derav, og/eller kalsium for forebyggelse avepitelial kreft

Info

Publication number
NO20034381D0
NO20034381D0 NO20034381A NO20034381A NO20034381D0 NO 20034381 D0 NO20034381 D0 NO 20034381D0 NO 20034381 A NO20034381 A NO 20034381A NO 20034381 A NO20034381 A NO 20034381A NO 20034381 D0 NO20034381 D0 NO 20034381D0
Authority
NO
Norway
Prior art keywords
metabolites
vitamin
epithelial cancer
prevention
calcium
Prior art date
Application number
NO20034381A
Other languages
English (en)
Other versions
NO20034381L (no
Inventor
Hans Henrik Raskov
Original Assignee
Colotech As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/825,891 external-priority patent/US6703380B2/en
Application filed by Colotech As filed Critical Colotech As
Publication of NO20034381D0 publication Critical patent/NO20034381D0/no
Publication of NO20034381L publication Critical patent/NO20034381L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NO20034381A 2001-04-05 2003-10-01 Kombinasjonsdose av cyklooksygenaseinhibitor, en vitamin-D3-omfattende analog og metabolitter derav, og/eller kalsium for forebyggelse avepitelial kreft NO20034381L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/825,891 US6703380B2 (en) 1999-09-29 2001-04-05 Prevention of cancer
PCT/DK2002/000231 WO2002080889A2 (en) 2001-04-05 2002-04-05 A combination dosage of a cyclooxygenase (cox) inhibitor, a vitamin d3 including analogues and metabolites thereof and/or calcium for prevention of epithelial cancer

Publications (2)

Publication Number Publication Date
NO20034381D0 true NO20034381D0 (no) 2003-10-01
NO20034381L NO20034381L (no) 2003-12-05

Family

ID=25245159

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034381A NO20034381L (no) 2001-04-05 2003-10-01 Kombinasjonsdose av cyklooksygenaseinhibitor, en vitamin-D3-omfattende analog og metabolitter derav, og/eller kalsium for forebyggelse avepitelial kreft

Country Status (12)

Country Link
EP (1) EP1389122B1 (no)
AT (1) ATE444072T1 (no)
AU (1) AU2002338311B2 (no)
CA (1) CA2445940C (no)
DE (1) DE60233869D1 (no)
DK (1) DK1389122T3 (no)
ES (1) ES2334215T3 (no)
IS (1) IS6976A (no)
NO (1) NO20034381L (no)
NZ (1) NZ529104A (no)
PT (1) PT1389122E (no)
WO (1) WO2002080889A2 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20135701L (fi) * 2013-06-26 2014-12-27 Mas Metabolic Analytical Services Oy Farmaseuttisesti käyttökelpoinen ja turvallinen kombinaatio käytettäväksi merkittävien sairauksien hoidossa

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948443A (en) * 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
DK1220676T3 (da) * 1999-09-29 2005-09-05 Colotech As Forebyggelse af colorektal cancer

Also Published As

Publication number Publication date
NZ529104A (en) 2004-05-28
CA2445940C (en) 2010-08-24
NO20034381L (no) 2003-12-05
WO2002080889A3 (en) 2003-02-20
DE60233869D1 (de) 2009-11-12
IS6976A (is) 2003-10-03
ES2334215T3 (es) 2010-03-08
PT1389122E (pt) 2009-12-23
EP1389122B1 (en) 2009-09-30
CA2445940A1 (en) 2002-10-17
WO2002080889A2 (en) 2002-10-17
EP1389122A2 (en) 2004-02-18
DK1389122T3 (da) 2010-02-01
AU2002338311B2 (en) 2006-08-10
ATE444072T1 (de) 2009-10-15

Similar Documents

Publication Publication Date Title
MXPA05011208A (es) Uso de ivermectina para el tratamiento de desordenes dermatologicos.
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
GT200500137A (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis.
HUP0202570A1 (hu) Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk
CL2019002218A1 (es) Formulaciones de combinación triple y métodos para tratar o reducir el riesgo de enfermedad cardiovascular.
BRPI0507482A (pt) combinação de (a) um inibidor de dna topoisomerase e (b) um inibidor de iap
NO20092763L (no) Isosorbid mononitrat derivater for behandling av tarmlidelser
PT1220676E (pt) Prevencao do cancro colorrectal
NO20064753L (no) Kombinasjonsterapi
CL2004002030A1 (es) Uso de interferon y ribavirina porque sirve para preparar un medicamento para tratar infecciones virales; composicion farmaceutica que comprende interferon, ribavirina y opcionalmente antioxidante; kit y su uso para preparar un medicamento para trata
TW200618807A (en) Prevention and therapeutical agent for hepatitis C virus infection
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
BRPI0519006A2 (pt) uso de um inibidor de fbpase, kit de uma composiÇço farmacÊutica, uso de uma preparaÇço de biguanida e um inibidor de fbpase, agente terapÊutico para diabetes melito, e, combinaÇço de agentes terapÊuticos
NO20034381L (no) Kombinasjonsdose av cyklooksygenaseinhibitor, en vitamin-D3-omfattende analog og metabolitter derav, og/eller kalsium for forebyggelse avepitelial kreft
BRPI0418801A (pt) métodos de tratamento, controle ou prevenção de um cáncer especìfico, e de uma doença associada com angiogênese indesejada, de redução ou prevenção de um efeito adverso, composição farmacêutica, e, kit
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption
BRPI0509305A (pt) uso de um sensibilizador insulìnico, composição farmecêutica, e , kit
PT1490049E (pt) Citalopram para o tratamento da pre3ssao sanguinia elevada.
ATE346080T1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
DE10292147D2 (de) Physiologisch verträgliche Kalium-und Magnesiumsalze enthaltendes pharmazeutisches Präparat sowie dessen Verwendung zur Prophylaxe und/oder Therapie von QT-Zeitverlängerungen
CL2004001263A1 (es) Composicion farmaceutica que comprende lamivudina, estavudina y efavirenzo, o derivados de ellos, kit farmaceutico; procedimiento para su preparacion; y uso en la preparacion de un medicamento para el tratamiento o prevencion de infecciones virales,
BRPI0407174A (pt) Regime de administração para nelfinavir
AR043241A1 (es) Terapia combinada que comprende un derivado de indolpirrol-carbazol y otro agente antitumoral
PL1700597T3 (pl) Kompozycja farmaceutyczna do podawania na skórę, zawierająca łącznie ubidekarenon, despantenol oraz chlorheksydynę lub jej farmakologicznie dopuszczalną sól

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT POSTBOKS 1003 SENTRUM OSLO, 0

FC2A Withdrawal, rejection or dismissal of laid open patent application